Earnings Preview — 5177 total
Stifel Financial Corp. reports after the close on June 9 at a moment when the stock's own short sellers appear to be backing away — the setup is less about positioning pressure and more about whether the market…
Smith & Nephew heads into its June 9 trading update with the lending market flashing its tightest signal in months — a more charged setup than the muted price action suggests. The borrow story is striking. Availability…
Entergy Corporation heads into its June 9 earnings release with options positioning still aggressively tilted toward the upside — a stance that has barely shifted since the call-heavy skew was flagged three days…
Dr. Reddy's Laboratories carries the same structural divide into its June 9 print that has defined this entire preview cycle — short sellers sitting near their highs, options traders showing no concern whatsoever. The…
NANO arrives at its June 5 earnings event on a sharp divergence — up 18% over the past month, down 8% across the past week, and closing yesterday at €31.24 after a 3.7% single-day bounce. That tug-of-war between the…
Quanex Building Products Corporation enters its fiscal Q2 2026 earnings print today with a notable uptick in short positioning — and a price chart that has been sliding all week. Short sellers have been adding to…
MSTR enters its June 8 earnings call with a bruising month behind it and short sellers showing no sign of retreat — the question now is whether the bitcoin treasury thesis can survive the scrutiny of a live Q&A at…
Honeywell International arrives at its June 8 earnings event having shed 6.5% over the past week to $217.64 — a notable pullback that reframes the setup compared to the more constructive picture from Tuesday's trader…
Rubrik reports its latest quarterly results today with call-side positioning at the most extreme bullish reading in the stock's history — even after a 3% pullback yesterday that brought shares to $77.00. The options…
RDDT enters its June 8 earnings call with options traders at their most bullish in nearly a year — a sharp contrast to the cautious hedging that defined most of the spring. The options signal is the standout heading…
APO heads into its June 8 results with options traders expressing the most bullish positioning in months — even as insiders quietly trim. The clearest signal comes from the options market. The put/call ratio dropped to…
Ares Management Corporation heads into its June 8 earnings release with a striking divergence: short sellers are pressing harder than at any point in months, yet the stock is climbing against a tide of peer-group…
SJM heads into its June 9 earnings event having already survived one print this earnings cycle — and with short sellers now firmly in retreat, the debate has shifted squarely to whether the analyst community's…
TLK — the NYSE-listed ADR of Indonesian state telecom Perusahaan Perseroan PT Telekomunikasi Indonesia — reports on June 8 against a backdrop of mounting political risk and a weakening rupiah, two forces that have…
ORCL heads into Monday's June 8 print having lapped the Street: the stock closed Thursday at $236.34, up 31% in a month and 16% in the past week alone, and the consensus mean price target of $251 is now barely 6% above…
NFLX reports Q2 results tonight carrying the weight of a 12% single-day collapse from its last earnings release — and the positioning data heading into the print tells a story of measured caution rather than outright…
Blue Owl Capital reports this morning with short interest at a six-week high, options traders turning decisively less defensive, and the Street split between targets ranging from $9.50 to $21 — a setup that makes…
ABNB heads into Thursday's results with options traders taking their most constructive stance in months — a notable shift from the defensive posture that dominated all spring. The options signal is the clearest new…
AVGO has delivered its Q2 print and broken above the analyst target cluster that defined the pre-earnings setup — the question now is whether the Street chases the stock higher or whether consensus begins to look…
Aclaris Therapeutics reports Q1 results this morning with options traders running their most defensive positioning of the past year — even as the analyst community has rarely been more constructive on the stock. The…
